Using 'number needed to treat' to express the magnitudes of benefit of ultraviolet B phototherapy and of antitumour necrosis factor-α therapies for psoriasis

British Journal of Dermatology

Volumn 162, Issue 2, 2010, Pages 456-457

  Dawe, R S ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Antitumour necrosis factor therapies; Biological; Placebo; Treatment comparisons; Ultraviolet B

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; METHOTREXATE; PLACEBO; PSORALEN;

BIOLOGICAL THERAPY; CLINICAL TRIAL; DISEASE SEVERITY; HUMAN; INTERMETHOD COMPARISON; LETTER; PHOTOTHERAPY; PRIORITY JOURNAL; PSORIASIS; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ANTIBODIES, MONOCLONAL; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PSORIASIS; RISK ASSESSMENT; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET THERAPY;

EID: 74349083669     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09555.x     Document Type: Letter

References (9)

1. Dharamsi JW, Bhosle M, Balkrishnan R et al. Using 'number needed to treat' to help conceptualize the magnitude of benefit and risk of tumour necrosis factor-alpha inhibitors for patients with severe psoriasis. Br J Dermatol 2009 161 : 605 616.
2. Manriquez JJ, Villouta MF, Williams HC. Evidence-based dermatology: number needed to treat and its relation to other risk measures. J Am Acad Dermatol 2007 56 : 664 671.
3. Chaudhari U, Romano P, Mulcahy LD et al. Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial. Lancet 2001 357 : 1842 1847.
4. Saurat JH, Stingl G, Dubertret L et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION). Br J Dermatol 2008 158 : 558 566.
5. Edwards SJ, Clarke MJ, Wordsworth S et al. Indirect comparisons of treatments based on systematic reviews of randomised controlled trials. Int J Clin Pract 2009 63 : 841 854.
6. Bansback N, Sizto S, Sun H et al. Efficacy of systemic treatments for moderate to severe plaque psoriasis: systematic review and meta-analysis. Dermatology 2009 219 : 209 218.
7. Boztepe G, Karaduman A, Sahin S et al. The effect of maintenance narrow-band ultraviolet B therapy on the duration of remission for psoriasis: a prospective randomized clinical trial. Int J Dermatol 2006 45 : 245 250.
8. Koek MB, Buskens E, van Weelden H et al. Home versus outpatient ultraviolet B phototherapy for mild to severe psoriasis: pragmatic multicentre randomised controlled non-inferiority trial (PLUTO study). BMJ 2009 338 : b1542.
9. Gottlieb AB, Matheson RT, Lowe N et al. A randomized trial of etanercept as monotherapy for psoriasis. Arch Dermatol 2003 139 : 1627 1632.